Auf dieser Seite
RZLT Rezolute, Inc. - Common Stock (NV)
NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗ 10-K/10-Q Sep 24, 2026
$4,01
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$1,0752-Wochen-Tief
$11,4652-Wochen-Hoch
Marktkapitalisierung (MRQ)
$386M
P/E
-5.3
EPS
$-0.75
Ihre Abzeichen
52W-Spanne
$1–$11
Analystenbewertung
BUY
Kursziel
$10
P/E
-5.3
ROE
-67.8%
Nettogewinnmarge
·
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
RZLT Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$4.00
Marktkapitalisierung (MRQ)
$386M
P/E
-5.3
EPS
$-0.75
ROE
-67.8%
52W-Spanne
$1–$11
RZLT Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
Aktiensplits
| Ex-Datum | Split | Typ |
|---|---|---|
| 13. Oktober 2020 | 1-for-50 | Umgekehrt |
| 1. Mai 2014 | 1-for-6 | Umgekehrt |
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
EPS$-0.752021-06-30 → 2026-06-30
Freier Cashflow·2019-06-30 → 2023-06-30
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | RZLT | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E | -5.35-Jahres-Durchschnitt ≈-3.6 | ≈-3.6 | · | · | |
| K/B (MRQ) | 3.85-Jahres-Durchschnitt ≈2.1 | ≈2.1 | 3.8 | Überbewertet | |
| Price / Cash Flow (Kurs / Cashflow) | -6.05-Jahres-Durchschnitt ≈-4.3 | ≈-4.3 | · | · | |
| Price / Tangible Book (Kurs / Materieller Buchwert) | 3.85-Jahres-Durchschnitt ≈2.1 | ≈2.1 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | RZLT | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| ROA | -53.8%5-Jahres-Durchschnitt ≈-47.0% | ≈-47.0% | -39.0% | Schwach | |
| ROE | -67.8%5-Jahres-Durchschnitt ≈-55.9% | ≈-55.9% | -59.5% | Im Einklang |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | RZLT | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 9.75-Jahres-Durchschnitt ≈23.9 | ≈23.9 | 6.6 | Starke Liquidität | |
| Quick Ratio | 9.45-Jahres-Durchschnitt ≈23.5 | ≈23.5 | 3.0 | Starke Liquidität |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Für diese Kennzahlengruppe sind noch keine Daten verfügbar
Noch nicht genügend Fundamentaldaten vorhanden, um diese Kennzahlengruppe zu berechnen.
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Für diese Kennzahlengruppe sind noch keine Daten verfügbar
Noch nicht genügend Fundamentaldaten vorhanden, um diese Kennzahlengruppe zu berechnen.
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-9.8%
Nächster Bericht
Nov 04, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 31. Dezember 2026 | $-0.20 | $-0.15 | -32.5% | |
| 30. Juni 2026 | $-0.20 | $-0.15 | -32.5% | |
| 31. März 2026 | $-0.16 | $-0.18 | 12.3% | |
| 31. Dezember 2025 | $-0.22 | $-0.19 | -15.4% | |
| 30. September 2025 | $-0.18 | $-0.27 | 33.4% | |
| 30. Juni 2025 | $-0.26 | $-0.22 | -15.9% | |
| 31. März 2025 | $-0.27 | $-0.23 | -18.3% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $54M | $62M | $56M | $44M | $32M | $15M | $14M | $19M | $17M | $12M | $9M | $5M | |
| SG&A Expense | $29M | $18M | $15M | $12M | $9M | $8M | $6M | $7M | $9M | $8M | $6M | $6M | |
| Operating Expenses | $83M | $80M | $70M | $56M | $42M | $23M | $21M | $26M | $29M | $20M | $15M | $11M | |
| Operating Income | $-83M | $-80M | $-70M | $-56M | $-42M | $-23M | $-21M | $-26M | $-29M | $-20M | $-15M | $-11M | |
| Interest Expense | · | · | · | · | · | $375.0K | $0 | $5M | $689.0K | $1.6K | $5.0K | $6.7K | |
| Interest Income | · | · | · | · | · | · | · | · | $1.0K | $0 | $965 | $5.0K | |
| Other Non-op | · | $5M | $2M | $4M | $783.0K | $2M | $188.0K | $-5M | $-1M | $46.9K | $15.7K | $-664.5K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-78M | $-74M | $-68M | $-52M | $-41M | $-21M | $-20M | $-30M | $-30M | $-20M | $-15M | $-11M | |
| EPS (Basic) | $-0.75 | $-0.98 | $-1.33 | $-1.01 | $-2.26 | $-2.72 | · | · | · | · | · | · | |
| EPS (Diluted) | $-0.75 | $-0.98 | $-1.33 | $-1.01 | $-2.32 | $-2.72 | · | · | · | · | · | · | |
| Shares (Basic) | 103,907,114 | 75,999,290 | 51,466,150 | 51,187,000 | 18,197,000 | 7,671,000 | · | · | · | · | · | · | |
| Shares (Diluted) | 103,907,114 | 75,999,290 | 51,466,150 | 51,187,000 | 19,487,000 | 7,671,000 | · | · | · | · | · | · | |
| EBITDA | $-83M | $-80M | $-70M | $-56M | $-42M | · | $-21M | $-26M | · | $-20M | $-15M | $-11M |
Bilanz
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $11M | $94M | $70M | $16M | $150M | $41M | $77M | $38M | $2M | $4M | $4M | $5M | |
| Short-term Investments | $97M | $74M | $56M | $86M | · | · | · | · | · | · | · | · | |
| Inventory | · | · | · | · | · | · | · | · | · | · | · | $67.2K | |
| Prepaid Expense | $3M | $3M | $2M | $3M | $2M | $946.0K | $563.0K | $571.0K | $362.0K | · | · | · | |
| Other Current Assets | · | · | · | · | · | · | · | · | $361.9K | $442.0K | $430.1K | $387.5K | |
| Current Assets | $111M | $171M | $129M | $105M | $152M | $42M | $11M | $12M | $2M | $5M | $4M | $6M | |
| PP&E (Net) | $41.0K | $72.0K | $103.0K | $139.0K | $16.0K | $29.0K | $33.0K | $44.0K | $368.0K | $5M | $6M | $5M | |
| PP&E (Gross) | $210.0K | $210.0K | $210.0K | $210.0K | $56.0K | $56.0K | $47.0K | $47.0K | $886.0K | $7M | $7M | $5M | |
| Accum. Depreciation | $169.0K | $138.0K | $107.0K | $71.0K | $40.0K | $27.0K | $14.0K | $3.0K | $518.0K | $2M | $879.2K | $136.6K | |
| Intangibles | · | · | · | · | · | · | $0 | $29.0K | $37.0K | $44.3K | $51.6K | $58.9K | |
| Other Non-current Assets | · | · | · | · | · | · | · | · | · | · | $0 | · | |
| Total Assets | $113M | $175M | $133M | $124M | $152M | $43M | $11M | $12M | $3M | $11M | $11M | $11M | |
| Accounts Payable | $5M | $6M | $5M | $3M | $1M | $1M | $893.0K | $563.0K | $2M | $951.2K | $2M | $1M | |
| Current Liabilities | $11M | $12M | $10M | $5M | $2M | $2M | $3M | $8M | $6M | $2M | $2M | $2M | |
| Capital Leases | $276.0K | $983.0K | $2M | $2M | $80.0K | $187.0K | $165.0K | $0 | · | · | $0 | $23.1K | |
| Other Non-current Liabilities | · | · | · | · | · | · | $0 | $121.0K | $216.0K | $304.6K | $400.0K | $480.5K | |
| Total Liabilities | $12M | $13M | $12M | $8M | $3M | $17M | $4M | $10M | $6M | $2M | $2M | $2M | |
| Long-term Debt | · | · | · | · | · | $14M | $0 | $0 | $3M | · | · | · | |
| Common Stock | $96.0K | $87.0K | $53.0K | $37.0K | $34.0K | $8.0K | $6.0K | $4.0K | $62.0K | $49.2K | $35.1K | $24.3K | |
| Paid-in Capital | $582M | $566M | $450M | $377M | $359M | $194M | $155M | $129M | $90M | $73M | $53M | $38M | |
| Retained Earnings | $-481M | $-404M | $-329M | $-261M | $-209M | $-168M | $-147M | $-127M | $-94M | $-64M | $-44M | $-29M | |
| AOCI | $-119.0K | $-7.0K | $-79.0K | $-351.0K | · | · | · | · | · | · | · | · | |
| Stockholders' Equity | $101M | $162M | $121M | $116M | $149M | $26M | $7M | $2M | $-4M | $9M | $9M | $9M | |
| Liabilities + Equity | $113M | $175M | $133M | $124M | $152M | $43M | $11M | $12M | $3M | $11M | $11M | $11M | |
| Shares Outstanding | 96,405,982 | 86,995,985 | 53,245,824 | 36,827,000 | 33,582,000 | 8,352,000 | 5,867,000 | 4,208,000 | 62,166 | 49,228,640 | 35,110,916 | 24,338,219 |
Cashflow
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $31.0K | $31.0K | $36.0K | $30.0K | $13.0K | $13.0K | $18.0K | $49.0K | $1M | · | · | · | |
| Stock-based Comp | $14M | $7M | $7M | $7M | $4M | $4M | $3M | $3M | $5M | $6M | $4M | $3M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | |
| Amort. of Intangibles | · | · | · | · | · | · | $7.0K | $7.0K | $7.0K | $7.3K | $7.3K | $5.3K | |
| Restructuring | · | · | · | · | · | $201.0K | · | · | · | · | · | · | |
| Operating Cash Flow | $-65M | $-69M | $-57M | $-44M | $-40M | $-20M | $-24M | $-15M | $-14M | $-13M | $-10M | $-7M | |
| CapEx | · | · | · | $153.0K | · | · | $0 | $47.0K | $6.0K | · | · | · | |
| Investing Cash Flow | $-21M | $-15M | $49M | $-101M | · | $0 | $0 | $231.0K | $2M | $-195.4K | · | · | |
| Stock Issued | · | · | · | · | · | $0 | $24M | $0 | $4M | · | · | · | |
| Stock Repurchased | · | · | $3.0K | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | · | $-3.0K | · | · | · | $24M | $0 | · | · | · | · | |
| Financing Cash Flow | $2M | $107M | $63M | $12M | $149M | $52M | $23M | $25M | $10M | $14M | · | · | |
| Net Change in Cash | $-83M | $24M | $54M | $-134M | $109M | $31M | $-2M | $10M | · | · | · | · | |
| Free Cash Flow | · | · | · | $-45M | · | · | $-24M | $-15M | · | · | · | · |
Rentabilität
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -53.8% | -48.3% | -53.4% | -37.5% | -42.1% | · | -175.2% | -412.7% | · | -188.3% | -134.8% | -121.7% | |
| ROE | -67.8% | -56.9% | -71.4% | -42.5% | -40.8% | · | -229.9% | -951.1% | · | -234.4% | -167.6% | -147.0% |
Liquidität & Solvenz
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.7 | 14.4 | 13.4 | 20.2 | 61.8 | · | 3.3 | 1.4 | · | 2.8 | 2.6 | 3.6 | |
| Quick Ratio | 9.4 | 14.1 | 13.2 | 19.6 | 61.1 | · | 3.1 | 1.4 | · | 2.5 | 2.3 | 3.1 | |
| Interest Coverage | · | · | · | · | · | · | · | -5.2 | · | -12742.3 | -2967.1 | -1589.8 |
Pro Aktie
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.04 | $1.86 | $2.27 | $3.15 | $4.45 | · | $1.26 | $8.33 | · | $0.17 | $0.25 | $0.37 | |
| Cash Flow / Share | $-0.62 | $-0.91 | $-1.11 | $-0.87 | $-2.03 | · | · | · | · | · | · | · | |
| Cash / Share | $0.11 | $1.08 | $1.32 | $0.44 | $4.48 | · | $1.70 | $55.01 | · | $0.09 | $0.12 | $0.22 | |
| EPS (TTM) | $-0.75 | $-0.98 | $-1.33 | $-1.01 | $-2.32 | $-2.72 | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-78M | $-74M | $-68M | $-52M | $-41M | $-21M | $-20M | $-30M | $-30M | $-20M | $-15M | $-11M | |
| Market Cap | $501M | $388M | $229M | $73M | $108M | · | $27M | $2M | · | $2.78B | $1.76B | $2.37B | |
| P/E | -6.9 | -4.6 | -3.2 | -2.0 | -1.4 | -5.2 | · | · | · | · | · | · | |
| P/B | 5.0 | 2.4 | 1.9 | 0.6 | 0.7 | · | 3.7 | 1.2 | · | 326.2 | 200.1 | 262.1 | |
| P / Tangible Book | 5.0 | 2.4 | 1.9 | 0.6 | 0.7 | 4.6 | 3.7 | · | · | · | · | · | |
| P / Cash Flow | -7.8 | -5.6 | -4.0 | -1.6 | -2.7 | · | -1.1 | -0.1 | · | -208.9 | -167.4 | -335.2 | |
| P / FCF | · | · | · | -1.6 | · | · | -1.1 | -0.1 | · | · | · | · | |
| Earnings Yield | -14.4% | -22.0% | -30.9% | -51.0% | -71.8% | -19.1% | · | · | · | · | · | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $15M | $11M | $14M | $13M | $21M | $15M | $13M | $13M | $19M | $12M | $12M | $12M | $11M | $14M | $11M | $8M | |
| SG&A Expense | $7M | $6M | $10M | $7M | $5M | $5M | $4M | $4M | $4M | $4M | $3M | $4M | $3M | $3M | $3M | $3M | |
| Operating Expenses | $22M | $17M | $24M | $20M | $26M | $20M | $17M | $17M | $23M | $16M | $15M | $16M | $14M | $17M | $14M | $10M | |
| Operating Income | $-22M | $-17M | $-24M | $-20M | $-26M | $-20M | $-17M | $-17M | $-23M | $-16M | $-15M | $-16M | $-14M | $-17M | $-14M | $-10M | |
| Other Non-op | · | $1M | $1M | $2M | $1M | $1M | $1M | $2M | $126.0K | $-837.0K | $1M | $1M | $2M | $1M | $836.0K | $387.0K | |
| Net Income | $-20M | $-16M | $-23M | $-18M | $-24M | $-19M | $-16M | $-15M | $-23M | $-17M | $-14M | $-15M | $-13M | $-16M | $-14M | $-10M | |
| EPS (Basic) | $-0.19 | $-0.16 | $-0.22 | $-0.18 | $-0.27 | $-0.27 | $-0.22 | $-0.22 | $-0.44 | $-0.34 | $-0.27 | $-0.28 | $-0.26 | $-0.30 | $-0.26 | $-0.19 | |
| EPS (Diluted) | $-0.19 | $-0.16 | $-0.22 | $-0.18 | $-0.27 | $-0.27 | $-0.22 | $-0.22 | $-0.44 | $-0.34 | $-0.27 | $-0.28 | $-0.26 | $-0.30 | $-0.26 | $-0.19 | |
| Shares (Basic) | · | 104,040,292 | 103,687,064 | 103,422,647 | · | 70,031,041 | 69,940,319 | 69,736,150 | · | 50,812,332 | 51,408,000 | 51,409,000 | · | 51,409,000 | 51,410,000 | 50,528,000 | |
| Shares (Diluted) | · | 104,040,292 | 103,687,064 | 103,422,647 | · | 70,031,041 | 69,940,319 | 69,736,150 | · | 50,812,332 | 51,408,000 | 51,409,000 | · | 51,409,000 | 51,410,000 | 50,528,000 | |
| EBITDA | · | $-17M | $-24M | $-20M | · | $-20M | $-17M | $-17M | · | $-16M | $-15M | $-16M | · | $-17M | $-14M | $-10M |
Bilanz
| Kennzahl | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $11M | $11M | $12M | $9M | $94M | $15M | $9M | $10M | $70M | $6M | $13M | $8M | $16M | $34M | $147M | $154M | |
| Short-term Investments | $97M | $109M | $121M | $143M | $74M | $72M | $88M | $98M | $56M | $74M | $80M | $91M | $86M | $69M | · | · | |
| Prepaid Expense | $3M | $2M | $2M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $3M | $4M | $3M | $2M | $860.0K | $1M | |
| Current Assets | $111M | $122M | $135M | $155M | $171M | $89M | $99M | $110M | $129M | $82M | $96M | $103M | $105M | $106M | $148M | $156M | |
| PP&E (Net) | $41.0K | $49.0K | $57.0K | $64.0K | $72.0K | $80.0K | $87.0K | $95.0K | $103.0K | $110.0K | $119.0K | $129.0K | $139.0K | $149.0K | $160.0K | $83.0K | |
| PP&E (Gross) | $210.0K | · | · | · | $210.0K | · | · | · | $210.0K | · | · | · | $210.0K | · | · | · | |
| Accum. Depreciation | $169.0K | · | · | · | $138.0K | · | · | · | $107.0K | · | · | · | $71.0K | · | · | · | |
| Total Assets | $113M | $125M | $139M | $159M | $175M | $95M | $112M | $123M | $133M | $88M | $102M | $113M | $124M | $134M | $150M | $156M | |
| Accounts Payable | $5M | $3M | $4M | $3M | $6M | $7M | $3M | $2M | $5M | $3M | $4M | $2M | $3M | $3M | $3M | $1M | |
| Current Liabilities | $11M | $8M | $10M | $10M | $12M | $11M | $11M | $8M | $10M | $7M | $8M | $7M | $5M | $4M | $6M | $2M | |
| Capital Leases | $276.0K | $438.0K | $619.0K | $804.0K | $983.0K | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $49.0K | |
| Total Liabilities | $12M | $9M | $11M | $11M | $13M | $12M | $12M | $10M | $12M | $17M | $10M | $9M | $8M | $7M | $9M | $3M | |
| Common Stock | $96.0K | $96.0K | $96.0K | $91.0K | $87.0K | $61.0K | $61.0K | $55.0K | $53.0K | $40.0K | $40.0K | $37.0K | $37.0K | $37.0K | $37.0K | $37.0K | |
| Paid-in Capital | $582M | $578M | $573M | $569M | $566M | $462M | $460M | $458M | $450M | $377M | $381M | $379M | $377M | $376M | $374M | $372M | |
| Retained Earnings | $-481M | $-461M | $-445M | $-422M | $-404M | $-379M | $-361M | $-345M | $-329M | $-306M | $-289M | $-276M | $-261M | $-248M | $-233M | $-219M | |
| AOCI | $-119.0K | $-115.0K | $47.0K | $49.0K | $-7.0K | $43.0K | $64.0K | $289.0K | $-79.0K | $-78.0K | $-48.0K | $-284.0K | $-351.0K | $-132.0K | · | · | |
| Stockholders' Equity | $101M | $117M | $128M | $147M | $162M | $83M | $100M | $113M | $121M | $71M | $92M | $104M | $116M | $127M | $141M | $153M | |
| Liabilities + Equity | $113M | $125M | $139M | $159M | $175M | $95M | $112M | $123M | $133M | $88M | $102M | $113M | $124M | $134M | $150M | $156M | |
| Shares Outstanding | 96,405,982 | 96,292,331 | 95,547,998 | 91,036,700 | 86,995,985 | 60,542,914 | 60,535,000 | 55,394,000 | 53,245,824 | 40,132,000 | 39,625,000 | 36,827,000 | 36,827,000 | 36,827,000 | 36,827,000 | 36,827,000 |
Cashflow
| Kennzahl | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $8.0K | $8.0K | $7.0K | $8.0K | $8.0K | $7.0K | $8.0K | $8.0K | $7.0K | $9.0K | $10.0K | $10.0K | $9.0K | $11.0K | $7.0K | $3.0K | |
| Stock-based Comp | $4M | $4M | $3M | $3M | $2M | $2M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Operating Cash Flow | $-13M | $-14M | $-20M | $-17M | $-22M | $-17M | $-14M | $-16M | $-19M | $-15M | $-13M | $-11M | $-11M | $-18M | $-7M | $-8M | |
| CapEx | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $83.0K | $70.0K | |
| Investing Cash Flow | $12M | $12M | $23M | $-68M | $346.0K | $23M | $11M | $-49M | $20M | $9M | $18M | $3M | $-6M | $-95M | $-83.0K | $-70.0K | |
| Stock Repurchased | · | · | · | · | · | · | · | · | $0 | · | · | · | · | · | · | · | |
| Financing Cash Flow | $227.0K | $747.0K | $356.0K | $911.0K | $101M | $10.0K | $657.0K | $6M | $63M | $-3.0K | · | · | $0 | $0 | $0 | $12M | |
| Net Change in Cash | $-621.0K | $-708.0K | $3M | $-85M | $80M | $6M | $-2M | $-60M | $64M | $-7M | $4M | $-8M | $-18M | $-113M | $-8M | $4M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $-8M |
Rentabilität
| Kennzahl | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | · | -14.7% | -18.2% | -12.9% | · | -20.7% | -14.7% | -13.0% | · | -15.4% | -11.0% | -10.8% | · | -15.4% | -11.6% | -10.1% | |
| ROE | · | -16.2% | -20.0% | -13.9% | · | -24.6% | -16.4% | -14.2% | · | -17.2% | -11.9% | -11.3% | · | -17.5% | -13.3% | -11.3% |
Liquidität & Solvenz
| Kennzahl | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 15.8 | 14.2 | 15.2 | · | 8.4 | 9.3 | 13.8 | · | 11.8 | 12.0 | 14.3 | · | 24.1 | 23.4 | 64.1 | |
| Quick Ratio | · | 15.6 | 14.0 | 14.9 | · | 8.3 | 9.1 | 13.5 | · | 11.5 | 11.6 | 13.7 | · | 23.5 | 23.2 | 63.5 |
Pro Aktie
| Kennzahl | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | $1.21 | $1.34 | $1.62 | · | $1.36 | $1.65 | $2.05 | · | $1.77 | $2.31 | $2.81 | · | $3.46 | $3.84 | $4.16 | |
| Cash Flow / Share | · | · | · | $-0.17 | · | · | · | $-0.23 | · | · | · | $-0.21 | · | · | · | $-0.15 | |
| Cash / Share | · | $0.12 | $0.12 | $0.10 | · | $0.24 | $0.15 | $0.19 | · | $0.15 | $0.32 | $0.22 | · | $0.92 | $3.98 | $4.19 | |
| EPS (TTM) | · | $-0.83 | $-0.94 | $-0.94 | · | $-1.15 | $-1.22 | $-1.27 | · | $-1.15 | $-1.11 | $-1.10 | · | $-0.70 | $-1.05 | $-1.59 |
Bewertung (TTM)
| Kennzahl | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | · | $-81M | $-84M | $-77M | · | $-73M | $-71M | $-69M | · | $-58M | $-57M | $-56M | · | $-48M | $-44M | $-43M | |
| Market Cap | · | $294M | $225M | $856M | · | $176M | $297M | $269M | · | $102M | $39M | $49M | · | $71M | $76M | $101M | |
| P/E | · | -3.7 | -2.5 | -10.0 | · | -2.5 | -4.0 | -3.8 | · | -2.2 | -0.9 | -1.2 | · | -2.7 | -2.0 | -1.7 | |
| P/B | · | 2.5 | 1.8 | 5.8 | · | 2.1 | 3.0 | 2.4 | · | 1.4 | 0.4 | 0.5 | · | 0.6 | 0.5 | 0.7 | |
| P / Tangible Book | · | 2.5 | 1.8 | 5.8 | · | 2.1 | 3.0 | 2.4 | · | 1.4 | 0.4 | 0.5 | · | 0.6 | 0.5 | 0.7 | |
| P / Cash Flow | · | · | · | -49.1 | · | · | · | -16.8 | · | · | · | -4.6 | · | · | · | -13.3 | |
| Earnings Yield | · | -27.2% | -39.8% | -10.0% | · | -39.7% | -24.9% | -26.2% | · | -45.1% | -111.8% | -83.3% | · | -36.5% | -50.7% | -58.0% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Nettoergebnis | $-78M | $-74M | $-68M | $-52M | $-41M |
| Verwässerte EPS | $-0.75 | $-0.98 | $-1.33 | $-1.01 | $-2.32 |
| Kennzahl | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Liquiditätsgrad | 9.7 | 14.4 | 13.4 | 20.2 | 61.8 |
| Quick Ratio | 9.4 | 14.1 | 13.2 | 19.6 | 61.1 |
| Kennzahl | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Freier Cashflow | · | · | · | $-45M | · |
Institutionelle Eigentümer (13F) 154 Einreicher · $475.2M gesamt · Stand 30. September 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
154
Gehaltener Wert
$475.2M
Neue Positionen
41
Geschlossene Positionen
19
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 41 (+5 vs. Vorquartal) | 19 (-16 vs. Vorquartal) | 63 (+24 vs. Vorquartal) | 30 (-11 vs. Vorquartal) | +1.4M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| FEDERATED HERMES, INC. | $67.551.427 | 12.990.659 | 14,22% | Aktien |
| RA CAPITAL MANAGEMENT, L.P. | $49.114.203 | 9.445.039 | 10,34% | Aktien |
| BlackRock, Inc. | $40.135.113 | 7.718.291 | 8,45% | Aktien |
| Opaleye Management Inc. | $32.760.000 | 6.300.000 | 6,89% | Aktien |
| Balyasny Asset Management L.P. | $24.242.603 | 4.662.039 | 5,10% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $19.946.300 | 3.835.827 | 4,20% | Aktien |
| Siren, L.L.C. | $17.307.092 | 3.328.287 | 3,64% | Aktien |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $13.320.601 | 2.561.654 | 2,80% | Aktien |
| JENNISON ASSOCIATES LLC | $12.788.402 | 2.459.308 | 2,69% | Aktien |
| VANGUARD GROUP INC | $11.300.886 | 4.788.511 | 2,38% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $11.288.227 | 2.170.154 | 2,38% | Aktien |
| STATE STREET CORP | $9.620.666 | 1.850.128 | 2,02% | Aktien |
| D. E. Shaw & Co., Inc. | $9.564.656 | 1.839.357 | 2,01% | Aktien |
| MORGAN STANLEY | $8.417.671 | 1.618.783 | 1,77% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $7.772.960 | 1.494.800 | 1,64% | Kaufoption |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $7.179.879 | 1.380.746 | 1,51% | Aktien |
| GOLDMAN SACHS GROUP INC | $6.847.267 | 1.316.782 | 1,44% | Aktien |
| Nuveen, LLC | $6.735.087 | 1.295.209 | 1,42% | Aktien |
| KENNEDY CAPITAL MANAGEMENT LLC | $6.352.726 | 1.221.678 | 1,34% | Aktien |
| Blackstone Inc. | $5.631.220 | 1.082.927 | 1,19% | Aktien |
| AQR CAPITAL MANAGEMENT LLC | $5.241.400 | 1.007.962 | 1,10% | Aktien |
| Affinity Asset Advisors, LLC | $5.200.000 | 1.000.000 | 1,09% | Aktien |
| GREAT POINT PARTNERS LLC | $4.949.407 | 951.809 | 1,04% | Aktien |
| Ikarian Capital, LLC | $4.862.062 | 935.012 | 1,02% | Aktien |
| Squadron Capital Management LLC | $4.680.000 | 900.000 | 0,98% | Kaufoption |
| DIMENSIONAL FUND ADVISORS LP | $4.631.598 | 890.733 | 0,97% | Aktien |
| 22NW, LP | $4.267.396 | 820.653 | 0,90% | Aktien |
| Velan Capital Investment Management LP | $3.900.000 | 750.000 | 0,82% | Aktien |
| BANK OF AMERICA CORP /DE/ | $3.797.726 | 730.332 | 0,80% | Aktien |
| NORTHERN TRUST CORP | $3.771.409 | 725.271 | 0,79% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $3.762.658 | 723.588 | 0,79% | Aktien |
| Woodline Partners LP | $3.181.344 | 611.797 | 0,67% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $2.969.392 | 571.037 | 0,62% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $2.689.617 | 517.234 | 0,57% | Aktien |
| J. Goldman & Co LP | $2.602.106 | 500.405 | 0,55% | Aktien |
| Integral Health Asset Management, LLC | $2.600.000 | 500.000 | 0,55% | Aktien |
| UBS Group AG | $2.579.371 | 496.033 | 0,54% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $2.241.580 | 431.073 | 0,47% | Aktien |
| Squadron Capital Management LLC | $2.097.732 | 403.410 | 0,44% | Aktien |
| Vestal Point Capital, LP | $1.991.595 | 382.999 | 0,42% | Aktien |
| Knott David M Jr | $1.924.000 | 370.000 | 0,40% | Aktien |
| XTX Topco Ltd | $1.839.084 | 353.670 | 0,39% | Aktien |
| Driehaus Capital Management LLC | $1.505.499 | 289.519 | 0,32% | Aktien |
| BOOTHBAY FUND MANAGEMENT, LLC | $1.492.166 | 286.955 | 0,31% | Aktien |
| Susquehanna Portfolio Strategies, LLC | $1.454.133 | 279.641 | 0,31% | Aktien |
| JANE STREET GROUP, LLC | $1.372.171 | 263.879 | 0,29% | Aktien |
| Schonfeld Strategic Advisors LLC | $1.371.478 | 263.746 | 0,29% | Aktien |
| Point72 Europe (London) LLP | $1.200.759 | 127.740 | 0,25% | Aktien |
| FMR LLC | $1.123.808 | 216.117 | 0,24% | Aktien |
| Bank of New York Mellon Corp | $1.103.804 | 212.270 | 0,23% | Aktien |
Aktivisten & 5%+-Eigentümer 13 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Genexine, Inc. ×2 Einreichungen | 3. Mai 2023 | · | Erste Einreichung | · | SEC |
| Handok, Inc. | 31. März 2020 | · | Erste Einreichung | · | SEC |
| Steve Howe | 24. Januar 2014 | · | Erste Einreichung | · | SEC |
| Theodore Kalem | 11. Februar 2013 | · | Erste Einreichung | Passive Anlage | SEC |
| Nickolay Kukekov | 8. Februar 2013 | · | Erste Einreichung | Passive Anlage | SEC |
| Sankaram Mantripragada ×2 Einreichungen | 8. Februar 2013 | · | Erste Einreichung | Passive Anlage | SEC |
| Konus Advisory Group, Inc., Hoyoung Huh, Nevan Elam | 8. Februar 2013 | · | Erste Einreichung | Passive Anlage | SEC |
| Nicht offengelegter meldender Beteiligter | 14. September 2012 | · | Erste Einreichung | · | SEC |
| Nicht offengelegter meldender Beteiligter | 14. September 2012 | · | Erste Einreichung | · | SEC |
| Nicht offengelegter meldender Beteiligter | 14. September 2012 | · | Erste Einreichung | · | SEC |
| Juemin Chu | 14. Februar 2012 | · | Erste Einreichung | Passive Anlage | SEC |
| Orit Wolkin | 14. Februar 2012 | · | Erste Einreichung | Passive Anlage | SEC |
| KAEYO Investments Ltd. | 14. Februar 2012 | · | Erste Einreichung | Passive Anlage | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 25 Insider · 10 Führungskräfte · 14 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Nevan C Elam | CEO | 2. Juli 2026 F | 605.497 | 1 | 0 | $50.880 |
| Daron Evans | CFO | 21. Oktober 2026 G | 11.000 | 4 | 0 | $108.225 |
| Keith A. Vendola | Chief Financial Officer | 31. Juli 2019 A | · | 0 | 0 | $0 |
| Nir Bar | President and Treasurer | 4. September 2012 S | 0 | 0 | 0 | $0 |
| Sunil Ratilal Karnawat | Chief Commercial Officer | 2. September 2026 F | 69.275 | 2 | 0 | $19.600 |
| Brian Kenneth Roberts | Chief Medical Officer | 2. Juli 2026 F | 293.851 | 1 | 0 | $47.600 |
| Sankaram Mantripragada | Chief Scientific Officer | 31. Juli 2019 A | · | 0 | 0 | $0 |
| Morgan Fields | Chief Accounting Officer | 31. Oktober 2016 A | · | 0 | 0 | $0 |
| Hoyoung Huh | Chairman, Scientific Adv. Bd. | 31. Oktober 2016 A | 5.057.693 | 0 | 0 | $0 |
| Guy Turnowski | Secretary | 4. September 2012 S | 0 | 0 | 0 | $0 |
| Wladimir Hogenhuis | Direktor | 16. Dezember 2025 P | 119.675 | 1 | 0 | $9.548 |
| Philippe Fauchet | Direktor | 19. November 2025 A | 55.500 | 0 | 0 | $0 |
| Erik Harris | Direktor | 19. November 2025 A | 21.000 | 0 | 0 | $0 |
| Young-Jin Kim | Direktor | 19. November 2025 A | 170.950 | 0 | 0 | $0 |
| Nerissa Kreher | Direktor | 19. November 2025 A | 58.576 | 0 | 0 | $0 |
| Gil M Labrucherie | Direktor | 19. November 2025 A | 55.500 | 0 | 0 | $0 |
| HANDOK, INC. | Direktor | 22. Juli 2022 P | 5.942.617 | 0 | 0 | $0 |
| David F Welch | Direktor | 10. März 2017 P | 1.811.415 | 0 | 0 | $0 |
| Barry Michael Sherman | Direktor | 31. Oktober 2016 A | · | 0 | 0 | $0 |
| Steve Howe | Direktor | 30. April 2014 A | · | 0 | 0 | $0 |
| Genexine Inc. | 10%-Eigentümer | 26. April 2019 C | 91.300.933 | 0 | 0 | $0 |
| Konus Advisory Group, Inc. | 10%-Eigentümer | 31. März 2014 J | 5.057.693 | 0 | 0 | $0 |
| Jue Min Chu | 10%-Eigentümer | 4. September 2012 S | 0 | 0 | 0 | $0 |
| KAEYO INVESTMENTS LTD | 10%-Eigentümer | 4. September 2012 S | 0 | 0 | 0 | $0 |
| Orit Wolkin | 10%-Eigentümer | 4. September 2012 S | 0 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 22 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0,79% | 77.705 NS | 31. Juli 2026 | N-PORT |
| JSML · Janus Detroit Street Trust | 0,42% | 320.855 NS | 31. Juli 2026 | N-PORT |
| IWC · iShares Trust | 0,08% | 264.133 SH | 11. September 2026 | Täglich |
| VFMO · VANGUARD WELLINGTON FUND | 0,03% | 130.974 SH | 19. August 2026 | Täglich |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 59.002 SH | 19. August 2026 | Täglich |
| RSSL · Global X Funds | 0,01% | 37.404 NS | 31. Juli 2026 | N-PORT |
| IWM · iShares Trust | 0,01% | 2.027.959 SH | 11. September 2026 | Täglich |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 1.005.418 SH | 19. August 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 450.381 SH | 19. August 2026 | Täglich |
| DFAS · Dimensional ETF Trust | 0,01% | 319.926 NS | 31. Juli 2026 | N-PORT |
| IWO · iShares Trust | 0,00% | 97.914 SH | 11. September 2026 | Täglich |
| DFSU · Dimensional ETF Trust | 0,00% | 12.923 NS | 31. Juli 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 13.711 NS | 31. Juli 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 19.647 NS | 31. Juli 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 120.621 SH | 11. September 2026 | Täglich |
| DFAC · Dimensional ETF Trust | 0,00% | 50.203 NS | 31. Juli 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 6.281 NS | 31. Juli 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 2.744.647 SH | 19. August 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,00% | 10.825 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 5.900 SH | 19. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,00% | 187.511 SH | 19. August 2026 | Täglich |
| IWN · iShares Trust | · | 633.100 SH | 11. September 2026 | Täglich |
RZLT Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 17 Analysten
KAUF
Median-Ziel
$10.00
+149,7%
6 35,3%
Starker Kauf
9 52,9%
Kauf
2 11,8%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
10 Analysten · 2026-10-28Mittelwert-Ziel $9.80 +144,7%
← Unter allen Zielen
Aktueller Preis $4.00
Tief$6.00
Mittelwert$9.80
Hoch$15.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| RZLT | $501M | -6.9 | · | · | -67.8% | · |
| RGNX | $733M | -3.8 | 104.5% | -113.8% | -122.5% | · |
| ALLO | $314M | -1.6 | -76.8% | · | -59.9% | · |
| ASMB | $539M | -61.8 | 153.5% | -8.5% | -5.5% | · |
| EDIT | $201M | -1.1 | 25.4% | -395.0% | -688.8% | · |
| TECX | $391M | -5.2 | · | · | -27.7% | · |
| ALT | $400M | -3.6 | 105.0% | -214861.0% | -45.6% | · |
| CCCC | $185M | -1.5 | 1.0% | -292.1% | -48.8% | · |
| TRXB | · | · | · | · | · | · |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-K eingereicht Sep 24, 2026